Perturbation with Intrabodies Reveals That Calpain Cleavage Is Required for Degradation of Huntingtin Exon 1
2011

Calpain Cleavage is Required for Degradation of Huntingtin Exon 1

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Amber L. Southwell, Charles W. Bugg, Linda S. Kaltenbach, Denise Dunn, Stefanie Butland, Andreas Weiss, Paolo Paganetti, Donald C. Lo, Paul H. Patterson

Primary Institution: California Institute of Technology

Hypothesis

Calpain cleavage is necessary for the degradation of mutant huntingtin exon 1.

Conclusion

Calpain-mediated removal of the first 15 amino acids of mutant huntingtin exon 1 is essential for its degradation, which may have therapeutic implications for Huntington's disease.

Supporting Evidence

  • Intrabodies can increase the turnover of mutant huntingtin.
  • Calpain inhibitors block the effect of intrabodies on huntingtin clearance.
  • Mutant huntingtin fragments are more toxic than the full-length protein.
  • Calpain cleavage sites were predicted in the huntingtin sequence.
  • Binding of intrabodies can prevent the cleavage of huntingtin.

Takeaway

Scientists found that a special protein called calpain helps break down a harmful version of a protein that causes Huntington's disease, which could help in finding new treatments.

Methodology

The study used intrabodies to investigate the clearance mechanism of mutant huntingtin exon 1 in cell cultures and brain slice models.

Potential Biases

Potential bias may arise from the use of specific intrabodies that could influence the results.

Limitations

The study's findings may not fully translate to in vivo conditions due to the use of cell cultures and specific inhibitors.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016676

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication